Literature DB >> 19826108

Axillary reverse mapping to prevent lymphedema after breast cancer surgery: defining the limits of the concept.

Seema A Khan.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19826108     DOI： 10.1200/JCO.2009.24.3311

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  The effectiveness of axillary reverse mapping in preventing breast cancer-related lymphedema: a meta-analysis based on randomized controlled trials.

Authors:  Xuhui Guo; Dechuang Jiao; Jiujun Zhu; Hui Xiao; Xin Zhao; Yue Yang; Yajie Zhao; Zhenzhen Liu
Journal:  Gland Surg       Date:  2021-04

2.  A randomized controlled trial comparing two types of pneumatic compression for breast cancer-related lymphedema treatment in the home.

Authors:  Caroline E Fife; Suzanne Davey; Erik A Maus; Renie Guilliod; Harvey N Mayrovitz
Journal:  Support Care Cancer       Date:  2012-05-02       Impact factor: 3.603

3.  Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedema.

Authors:  Kristen E Adams; John C Rasmussen; Chinmay Darne; I-Chih Tan; Melissa B Aldrich; Milton V Marshall; Caroline E Fife; Erik A Maus; Latisha A Smith; Renie Guilloid; Sunday Hoy; Eva M Sevick-Muraca
Journal:  Biomed Opt Express       Date:  2010-07-15       Impact factor: 3.732

4.  Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema.

Authors:  Pamela L Ostby; Jane M Armer; Paul S Dale; Margaret J Van Loo; Cassie L Wilbanks; Bob R Stewart
Journal:  J Pers Med       Date:  2014-08-18

5.  Complexities of Adherence and Post-Cancer Lymphedema Management.

Authors:  Pamela L Ostby; Jane M Armer
Journal:  J Pers Med       Date:  2015-11-16

6.  Diagnostic Accuracy of Clinical Measures Considering Segmental Tissue Composition and Volume Changes of Breast Cancer-Related Lymphedema.

Authors:  Eun Joo Yang; Seoung Yeon Kim; Woo Hyung Lee; Jae-Young Lim; Jaebong Lee
Journal:  Lymphat Res Biol       Date:  2018-01-17       Impact factor: 2.589
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.